91
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Development and evaluation of a screening tool to identify people with diabetes at increased risk of medication problems relating to hypoglycaemia and medication non-adherence

, &
Pages 10-25 | Received 03 Dec 2013, Accepted 14 Jul 2014, Published online: 30 Jan 2015

References

  • American Diabetes Association. (2013). Position statement: American diabetes association. Standards of medical care in diabetes. Diabetes Care, 36(Suppl. 1), S11–S66.
  • Australian Bureau of Statistics. (2001). Census of population and housing – SEIFA 2001. Retrieved from http://www.abs.gov.au/Websitedbs/D3110124.NSF/ 24e5997b9bf2ef35ca2567fb00299c59/a17dc48d988 ecf63ca256dad00005ea3!OpenDocument
  • Australian Medicines Handbook. (2007). Australian medicines handbook. Adelaide, SA: Author.
  • Baird, M. G., Bentley-Taylor, M. M., Carruthers, S. G., Dawson, K. G., LaPlante, L. E., Larochelle, P., … Talbot, P. (1984). A study of efficacy, tolerance and compliance of once daily versus twice daily metoprolol (Betaloc) in hypertension. Clinical and Investigative Medicine, 7(2), 95–102.
  • Berg, K. O., & Norman, K. (1996). Functional assessment of balance and gait. Clinics in Geriatric Medicine, 12(4), 705–723.
  • Bewick, V., Cheek, L., & Ball, J. (2004). Statistics review 13: Receiver operating characteristic curves. Critical Care, 8(6), 508–512.
  • Brown, B. G., Bardsley, J., Poulin, D., Hillger, L. A., Dowdy, A., Maher, V. M. G., … Knopp, R. H. (1997). Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol 100mg/dL in patients with hyperlipidemia and coronary artery disease. American Journal of Cardiology, 80(2), 111–115.
  • Charlson, M. E., Pompei, P., Ales, K. L., & Mackenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies. Development and validation. Journal of Chronic Disease, 40(5), 373–383.
  • Ciechanowski, P. S., Katon, W. J., & Russo, J. E. (2000). Depression and diabetes. Impact of depressive symptoms on adherence, function and costs. Archives of Internal Medicine, 160(21), 3278–3285.
  • Claxton, A. J., Cramer, J., & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Journal of Clinical Therapy, 23(8), 1296–1310.
  • Cohen, M. R. (1999). Medication errors: Causes, prevention, and risk management. Sudbury, MA: Jones and Barlett.
  • Cumbler, E., Wald, H., & Kutner, J. (2010). Lack of patient knowledge regarding hospital medications. Journal of Hospital Medicine, 5(2), 83–86.
  • Davis, L. (1992). Instrument review: Getting the most from your panel of experts. Applied Nursing Research, 5, 104–107.
  • Deyo, R. A., Cherkin, D. C., & Ciol, M. A. (1992). Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology, 45(6), 613–619.
  • Diabetes Australia. (2013). Diabetes management in general practice. In P. Harris, L. Mann, P. Phillips & C. Webster (Eds.), Guideline for type 2 diabetes (18th ed., pp. 1–96). Canberra, Australia: Diabetes Australia.
  • Diabetes Australia & Royal Australian College of General Practitioners. (2009). Diabetes management in general practice. In P. Harris, L. Mann, J. London, P. Phillips & C. Webster (Eds.), Guidelines for type 2 diabetes (15th ed., pp. 1–48). Sydney, Australia: Diabetes Australia.
  • DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160(14), 2101–2107.
  • Donnan, P. T., MacDonald, T. M., Morris, A. D., & Diabetes Audit and Research in Tayside Scotland/ Medicines Monitoring Unit Collaboration (DARTS/ MEMO). (2002). Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: A retrospective cohort study. Diabetic Medicine, 19(4), 279–284.
  • Fleiss, J. L. (1971). Measuring nominal scale agreement among many raters. Psychological Bulletin, 76(5), 378–382.
  • Fuller, D., & Watson, R. (2005). Validating a selfmedication risk assessment instrument. Clinical Effectiveness in Nursing, 9(1–2), 78–83.
  • Gandhi, T. K., Weingart, S. N., Borus, J., Seger, A. C., Peterson, J., Burdick, E., … Bates, D. W. (2003). Adverse drug events in ambulatory care. New England Journal of Medicine, 348(16), 1556–1564.
  • Gazmararian, J. A., Kripalani, S., Miller, M. J., Echt, K. V., Ren, J., & Rask, K. (2006). Factors associated with medication refill adherence in cardiovascular related diseases: A focus on health literacy. Journal of General Internal Medicine, 21(12), 1215–1221.
  • Girvin, B., McDermott, B. J., & Johnston, G. D. (1999). A comparison of Enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance. Journal of Hypertension, 17(11), 1627–1631.
  • Gordon, K., Smith, F. J., & Dhillon, S. D. (2005). The development and validation of a screening tool for the identification of patients experiencing medicationrelated problems. International Journal of Pharmacy Practice, 13(3), 187–194.
  • Grant, J. S., & Davis, L. L. (1997). Selection and use of content experts for instrument development. Research in Nursing and Health, 20(3), 269–274.
  • Hall, W. H., Ramachandran, R., Narayan, S., Jani, A. B., & Vijayakumar, S. (2004). An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer, 4, 94.
  • Houston-Miller, N., Hill, M., Kottke, T., Ockene, I. S., & The Expert Panel on Compliance. (1997). The multilevel compliance challenge: Recommendations for a call to action. A statement for healthcare professionals. Circulation, 95(4), 1085–1090.
  • Institute for Safe Medication Practices. (2008). Institute for safe medication practices list of high-alert medications (pp. 1–2). Horsham, PA: Author. Retrieved from http://www.ismp.org/Tools/highalertmedications. pdf
  • Isaksen, S. F., Jonassen, J., Malone, D. C., Billups, S. J., Carter, B. L., Sintek, C. D., & The IMROVE Investigators. (1999). Estimating risk factors for patients with potential drug-related problems using electronic pharmacy data. Annals of Pharmacotherapy, 33(4), 406–412.
  • Johnson, K. A., Nye, M., Hill-Besinque, K., & Cody, M. (1995). Measuring the impact of patient counseling in the outpatient pharmacy setting: Development and implementation of the counseling models for Kaiser Permanente/USC patient consultation study. Clinical Therapeutics, 17(5), 988–1002.
  • Kaplan, R. C., Bhalodkar, N. C., Brown, J., Edward, J., White, J., & Brown, D. L. (2004). Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. Preventive Medicine, 39(6), 1249–1255.
  • Kirkwood, B. R., & Sterne, J. A. C. (2003). Essential medical statistics (2nd ed.). Oxford, England: Blackwell Publishing.
  • Koecheler, J., Abramowitz, P., Swim, S., & Daniels, C. E. (1989). Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. American Journal of Hospital Pharmacy, 46(4), 729–732.
  • Landis, J. R., & Koch, G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174.
  • Langford, B. J., Jorgenson, D., Kwan, D., & Papoushek, C. (2006). Implementation of a self-administered questionnaire to identify patients at risk for medication-related problems in a family health center. Pharmacotherapy, 26(2), 260–268.
  • Leendertse, A. J., Egberts, A. C. G., Stoker, L. J., & van den Bemt, P. M. L. A. (2008). Frequency of and risk factors for preventable medication-related hospital admissions in The Netherlands. Archives of Internal Medicine, 168(17), 1890–1896.
  • Levy, H. B. (2003). Self-administered medication-risk questionnaire in an elderly population. Annals of Pharmacotherapy, 37(7–8), 982–987.
  • Mackin, R. S., & Arean, P. A. (2007). Cognitive and psychiatric predictors of medical treatment adherence among older adults in primary care clinics. International Journal of Geriatric Psychiatry, 22(1), 55–60.
  • MacLaughlin, E. J., Raehl, C. L., Treadway, A. K., Sterling, T. L., Zoller, D. P., & Bond, C. A. (2005). Assessing medication adherence in the elderly. Which tools to use in clinical practice? Drugs and Aging, 22(3), 231–255.
  • Merle, L., Laroche, M. L., Dantoine, T., & Charmes, J. P. (2005). Predicting and preventing adverse drug reactions in the very old. Drugs and Aging, 22(5), 375–392.
  • Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67–74.
  • Mullins, C. D. (2008). Moving from general predictors to patient-specific indicators of nonadherence. Clinical Therapeutics, 30(4), 716.
  • Odegard, P. S., & Gray, S. L. (2008). Barriers to medication adherence in poorly controlled diabetes mellitus. The Diabetes Educator, 34(4), 692–697.
  • Pallant, J. (2005). SPSS survival manual a step by step guide to data analysis using SPSS (2nd ed.). Sydney, NSW: Allen and Unwin.
  • Persell, S. D., Osborn, C. Y., Richard, R., Skripkauskas, S., & Wolf, M. S. (2007). Limited health literacy is a barrier to medication reconciliation in ambulatory care. Journal of General Internal Medicine, 22(11), 1523–1526.
  • Petrie, A., & Sabin, C. (2005). Medical statistics at a glance (2nd ed.). Oxford, England: Blackwell Publishing.
  • Saini, S. D., Schoenfeld, P., Kaulback, K., & Dubinsky, M. C. (2009). Effect of medication dosing frequency on adherence in chronic diseases. American Journal of Managed Care, 14(6), 22–34.
  • SPSS Inc. (2005). Statistical package for the social sciences (SPSS) (version 15.0 for windows grad pack) [computer software]. Chicago, IL: Author.
  • Stilley, C. S., Bender, C. M., Dunbar-Jacob, J., Sereika, S., & Ryan, C. M. (2010). The impact of cognitive function on medication management: Three studies. Health Psychology, 29(1), 50–55.
  • Streiner, D. R., & Norman, G. L. (2008). Health measurement scales. A practical guide to their development and use (4th ed.). Oxford, England: Oxford University Press.
  • Sundararajan, V., Henderson, T., Perry, C., Muggivan, A., Quan, H., & Ghali, W. A. (2004). New ICD-10 version of the Charlson comorbidity index predicts in hospital mortality. Journal of Clinical Epidemiology, 57(12), 1288–1294.
  • Svarstad, B. L., Chewning, B. A., Sleath, B. L., & Claesson, C. (1999). The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Education and Counseling, 37(2), 113–124.
  • Tabachnick, B. G., & Fidell, L. S. (2007). Using multivariate statistics (5th ed.). Boston, MA: Allyn and Bacon.
  • The University of Queensland. (2013). Introducing the international statistical classification of diseases in countries: Guidelines for implementing cause-of-death certification, morbidity and mortality coding. Retrieved from www.uq.edu.au/hishub
  • Waltz, C., & Bausell, R. B. (1981). Nursing research: Design, statistics and computer analysis. Philadelphia, PA: FA Davis Company.
  • Waltz, C., Strickland, O. L., & Lenz, E. R. (1984). Measurement in nursing research (2nd ed.). Philadelphia, PA: FA Davis Company.
  • Walz, L., Pettersson, B., Rosenqvist, U., Deleskog, A., Journath, G., & Wändell, P. (2014). Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes. Patient Prefer Adherence, 8, 593–601.
  • World Health Organisation. (2000). The international statistical classification of disease and related health problems 10th revision, Australian modification (CD-10-AM), tabular list of procedures ICD-10-AM. Retrieved from http://www.who.int/classifications/icd/en/
  • World Health Organisation. (2001). Health research methodology: A guide for training. Research methods (2nd ed., pp. 1–245). Manila, Philippines: Regional Office for the Western Pacific, WHO.
  • World Health Organisation. (2003). Screening for type 2 diabetes report of a World Health Organization and international diabetes federation meeting (pp. 1–53). Geneva, Switzerland: Author.
  • Yamada, K., Watanabe, K., Nemoto, N., Fujita, H., Chikaraishi, C., Yamauchi, K., … Kanba, S. (2006). Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study. Psychiatry Research, 141(1), 61–69.
  • Yang, Y., Thumula, V., Pace, P. F., Banahan, B. F. III, Wilkin, N. E., & Lobb, W. B. (2009). Predictors of medication nonadherence among patients with diabetes in Medicare part D programs: A retrospective cohort study. Clinical Therapeutics, 31(10), 2178–2188.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.